Article

Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Thyroid (Impact Factor: 3.84). 11/2007; 17(10):1013-8. DOI: 10.1089/thy.2007.0185
Source: PubMed

ABSTRACT The clinical manifestations of Graves' ophthalmopathy (GO) stem from a combination of increased orbital fat and extraocular muscle volume within the orbital space. Fibroblasts residing within orbital tissues are thought to be targets of autoimmune attack in the disease. Thyrotropin receptor (TSHr) mRNA and functional protein have been demonstrated in orbital fibroblasts from both normal individuals and GO patients, with higher levels present in the latter. Autoantibodies directed against TSHr or the insulin-like growth factor-1 (IGF-1) receptor have been implicated in GO pathogenesis. Evidence from our laboratory suggests that monoclonal TSHr autoantibodies (TRAbs) are potent stimulators of adipogenesis in GO orbital cells. Therefore, it is possible that circulating TRAbs in Graves' patients both stimulate overproduction of thyroid hormones and increase orbital adipose tissue volume. Antibodies to the IGF-1 receptor appear to impact GO pathogenesis through recruitment and activation of T-cells and stimulation of hyaluronan production, processes that play key roles in the development of inflammation and increased orbital tissue swelling. Although originally thought to represent another causative agent, antibodies to extraocular muscles are now generally thought to be secondary to extraocular muscle inflammation and damage.

0 Bookmarks
 · 
56 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introduction. The definition of severity and activity of Graves' ophthalmopathy (GO) comprises different parameters. The aim of this study is to select the most appropriate severity and activity criteria, respectively scores and to investigate a possible correlation among them. Subjects and methods. The study included 51 patients with GO (43 females, 8 males), mean age 46.8±11.2 years. The patients were evaluated by: clinical exam, laboratory parameters (TSH, FT4, FT3, thyroid autoantibodies) and imagistic means, performed in selected cases (CT or MRI). Results. The GO activity was assessed by the clinical activity score (CAS). We quantified the EUGOGO severity criteria, by allotting points for each selected parameter. According to the recommended criteria, the cases were divided into active (n=26) and inactive forms (n=25). There were no significant statistical differences regarding CAS between euthyroid cases (n=14) and dysthyroid cases (n=37). Serum thyroid receptor antibodies (TRAb) levels did not correlate with CAS or severity scores. Severity scores correlated significantly with CAS (Pearson correlation index 0.546, r2=0.290, p=0.0001). Conclusion. Active forms of GO showed higher severity scores than the inactive ones. The severity scores correlated significantly with CAS scores. Neither CAS, nor severity scores correlated significantly with the severity of thyrotoxicosis.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interwar Poland in the European context divorced great attention to the history of medicine and philosophy. Significant Medical History and Philosophy school took its part in Vilnius. Professor Stanislaw Trzebiński, a head of Vilnius Medical History and Philosophy school, investigated the development of Vilnius medicine in XVI-XIX centuries, constantly edited by a leading journal in the field of medical history and philosophy “The Archives for a Medical History and Philosophy as well as Nature history”. The medical history, medical logic, propedeutics, medical ethics were being taught in Stephen Bathory university Medical faculty. The aim of this paper is to make a short overview of the History of Medicine and Philosophy Department in the year 1922-1939. The activities and the most important achievements of the department will be reviewed in this review article. Correspondence to: aistis.zalnora@mf.vu.lt
    SVEIKATOS MOKSLAI. 01/2013; 23(2):151-154.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To better understand the pathogenesis of thyroid-associated orbitopathy (TAO) through elucidating the role of thyrotropin receptor (TSHR) and CD40 in the expression of interleukin-8 (IL-8) in peripheral blood fibrocytes. Fibrocytes infiltrate the orbit of patients with TAO, where they differentiate into fibroblasts. Fibrocyte precursors occur with increased frequency in the peripheral blood expressing TSHR and CD40 in TAO patients. We hypothesize that in vitro derived fibrocytes and peripheral blood fibrocyte precursors express proinflammatory chemoattractant molecules including IL-8 initiated by TSHR and CD40 signaling. Since nearly all TAO patients express activating antibodies to TSHR, this is particularly relevant for activation of peripheral blood fibrocytes. TSHR and CD40 expression on peripheral blood fibrocytes was determined by flow cytometry. IL-8 RNA was quantitated by real-time polymerase chain reaction. IL-8 protein production was measured by Luminex and flow cytometry. Thyroid-stimulating hormone and CD40 ligand-stimulated phosphorylation of Akt in peripheral blood fibrocytes was studied by flow cytometry. Both TSHR- and CD40-mediated signaling lead to IL-8 expression in mature fibrocytes. Fibrocyte precursors assayed directly from circulating peripheral blood demonstrate intracellular IL-8 expression with addition of thyroid-stimulating hormone or CD40 ligand. TSHR- and CD40-induced IL-8 production is mediated by Akt phosphorylation. Peripheral blood TSHR(+) and CD40(+) fibrocytes express IL-8 and may promote the recruitment of inflammatory cells, mitogenesis, and tissue remodeling in TAO. TSHR- and CD40-mediated IL-8 signaling is mediated by Akt. Delineating the molecular mechanisms of fibrocyte immune function may provide potential therapeutic targets for TAO.
    Transactions of the American Ophthalmological Society 07/2014; 112:26-37.